Aminoglycosides: Nursing Pharmacology Study Guide

Aminoglycosides are powerful bactericidal antibiotics used primarily for severe gram-negative infections. This note reviews the key drugs, mechanism, toxicities, monitoring parameters, and nursing priorities most commonly tested on the NCLEX.

Rapid Summary

• Aminoglycosides inhibit bacterial protein synthesis at the 30S ribosomal subunit.
• Used to treat severe gram-negative infections.
• Most dangerous adverse effects: ototoxicity and nephrotoxicity.
• Peak and trough levels must be monitored.
• Generally avoided in pregnancy.

Key Drugs

• Gentamicin — severe gram-negative infections; most commonly tested.
• Tobramycin — Pseudomonas infections, especially respiratory.
• Amikacin — resistant infections; broad gram-negative coverage.
• Streptomycin — tuberculosis treatment; rarely used today.

Mechanism of Action

• Bind to the 30S ribosomal subunit.
• Inhibit bacterial protein synthesis.
• Result in bacterial cell death (bactericidal).

Exam tip: Aminoglycosides are concentration-dependent killers — bacterial killing increases as drug concentration increases.

Spectrum

Aminoglycosides primarily target:

• Aerobic gram-negative bacteria
• Severe hospital-acquired infections

Key susceptible pathogens: Pseudomonas, Klebsiella, Enterobacter.

Clinical rule: Often combined with beta-lactam antibiotics for a synergistic effect.

Indications

• Sepsis
• Severe gram-negative infections
• Pseudomonas infections
• Endocarditis (combination therapy)
• Complicated urinary tract infections

Gentamicin is commonly used for serious hospital-acquired infections.

Side Effects

• Common: nausea and vomiting
• Serious: nephrotoxicity, ototoxicity, neuromuscular blockade

Exam priority: Ototoxicity and nephrotoxicity.

Symptoms of ototoxicity include tinnitus, hearing loss, and vertigo.

Labs to Monitor

• Peak levels — reflect drug effectiveness.
• Trough levels — reflect toxicity risk.
• BUN and creatinine — assess kidney function.
• Urine output

Key rule: High trough levels increase toxicity risk.

Contraindications

Avoid aminoglycosides in patients with:

• Severe renal impairment
• Preexisting hearing loss
• Neuromuscular disorders (e.g., myasthenia gravis)

Use cautiously in elderly patients.

Pregnancy Safety

• Aminoglycosides are generally avoided during pregnancy due to the risk of fetal ototoxicity (hearing damage).
• Safer alternatives should be used when possible.

Nursing Safety Rules

• Monitor peak and trough drug levels.
• Assess for tinnitus or hearing changes.
• Monitor renal function closely.
• Ensure adequate hydration.
• Avoid combining with other nephrotoxic drugs.

Common NCLEX Traps

• Ignoring tinnitus complaints.
• Not checking trough levels.
• Missing signs of kidney injury.
• Giving with other nephrotoxic drugs (e.g., vancomycin).

Key takeaways

• Aminoglycosides bind the 30S ribosome and are bactericidal, concentration-dependent killers.
• Reserved for severe gram-negative infections, often paired with beta-lactams for synergy.
• The two highest-yield toxicities are ototoxicity (tinnitus, hearing loss, vertigo) and nephrotoxicity.
• Monitor peak (effectiveness) and trough (toxicity) levels along with BUN/creatinine.
• Avoid in pregnancy, severe renal impairment, hearing loss, and neuromuscular disorders.
• Never combine routinely with other nephrotoxic agents such as vancomycin without close monitoring.